Myasthenia gravis surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The mainstay of surgical treatment of [[Myasthenia gravis|MG]] is [[thymectomy]]. [[Thymectomy]] means removing as much [[Thymus|thymic]] tissue as possible. This treatment is done for patients with [[thymoma]] and even in patients without [[thymoma]] and who have generalized [[Myasthenia gravis|MG]] with [[Acetylcholine receptor|AChR]] [[antibodies]]. | |||
== Indications == | |||
* This treatment is done for patients with [[thymoma]] and even in patients without [[thymoma]] and who have generalized [[Myasthenia gravis|MG]] with [[Acetylcholine receptor|AChR]] [[antibodies]].<ref name="pmid21860784">{{cite journal |vauthors=Romi F |title=Thymoma in myasthenia gravis: from diagnosis to treatment |journal=Autoimmune Dis |volume=2011 |issue= |pages=474512 |date=2011 |pmid=21860784 |pmc=3155972 |doi=10.4061/2011/474512 |url=}}</ref><ref name="pmid20402760">{{cite journal |vauthors=Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW |title=Guidelines for treatment of autoimmune neuromuscular transmission disorders |journal=Eur. J. Neurol. |volume=17 |issue=7 |pages=893–902 |date=July 2010 |pmid=20402760 |doi=10.1111/j.1468-1331.2010.03019.x |url=}}</ref><ref name="pmid20842584">{{cite journal |vauthors=Jani-Acsadi A, Lisak RP |title=Myasthenia gravis |journal=Curr Treat Options Neurol |volume=12 |issue=3 |pages=231–43 |date=May 2010 |pmid=20842584 |doi=10.1007/s11940-010-0070-0 |url=}}</ref><ref name="pmid20927659">{{cite journal |vauthors=Kumar V, Kaminski HJ |title=Treatment of myasthenia gravis |journal=Curr Neurol Neurosci Rep |volume=11 |issue=1 |pages=89–96 |date=February 2011 |pmid=20927659 |doi=10.1007/s11910-010-0151-1 |url=}}</ref><ref name="pmid27358333">{{cite journal |vauthors=Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P |title=International consensus guidance for management of myasthenia gravis: Executive summary |journal=Neurology |volume=87 |issue=4 |pages=419–25 |date=July 2016 |pmid=27358333 |pmc=4977114 |doi=10.1212/WNL.0000000000002790 |url=}}</ref><ref name="pmid27509100">{{cite journal |vauthors=Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR |title=Randomized Trial of Thymectomy in Myasthenia Gravis |journal=N. Engl. J. Med. |volume=375 |issue=6 |pages=511–22 |date=August 2016 |pmid=27509100 |pmc=5189669 |doi=10.1056/NEJMoa1602489 |url=}}</ref> | |||
==Surgery== | ==Surgery== | ||
* The mainstay of surgical treatment of [[Myasthenia gravis|MG]] is [[thymectomy]]. [[Thymectomy]] means removing as much [[Thymus|thymic]] tissue as possible.<ref name="pmid18567883">{{cite journal |vauthors=Sonett JR, Jaretzki A |title=Thymectomy for nonthymomatous myasthenia gravis: a critical analysis |journal=Ann. N. Y. Acad. Sci. |volume=1132 |issue= |pages=315–28 |date=2008 |pmid=18567883 |doi=10.1196/annals.1405.004 |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 18:23, 28 November 2018
|
Myasthenia gravis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myasthenia gravis surgery On the Web |
|
American Roentgen Ray Society Images of Myasthenia gravis surgery |
|
Risk calculators and risk factors for Myasthenia gravis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The mainstay of surgical treatment of MG is thymectomy. Thymectomy means removing as much thymic tissue as possible. This treatment is done for patients with thymoma and even in patients without thymoma and who have generalized MG with AChR antibodies.
Indications
- This treatment is done for patients with thymoma and even in patients without thymoma and who have generalized MG with AChR antibodies.[1][2][3][4][5][6]
Surgery
- The mainstay of surgical treatment of MG is thymectomy. Thymectomy means removing as much thymic tissue as possible.[7]
References
- ↑ Romi F (2011). "Thymoma in myasthenia gravis: from diagnosis to treatment". Autoimmune Dis. 2011: 474512. doi:10.4061/2011/474512. PMC 3155972. PMID 21860784.
- ↑ Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW (July 2010). "Guidelines for treatment of autoimmune neuromuscular transmission disorders". Eur. J. Neurol. 17 (7): 893–902. doi:10.1111/j.1468-1331.2010.03019.x. PMID 20402760.
- ↑ Jani-Acsadi A, Lisak RP (May 2010). "Myasthenia gravis". Curr Treat Options Neurol. 12 (3): 231–43. doi:10.1007/s11940-010-0070-0. PMID 20842584.
- ↑ Kumar V, Kaminski HJ (February 2011). "Treatment of myasthenia gravis". Curr Neurol Neurosci Rep. 11 (1): 89–96. doi:10.1007/s11910-010-0151-1. PMID 20927659.
- ↑ Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P (July 2016). "International consensus guidance for management of myasthenia gravis: Executive summary". Neurology. 87 (4): 419–25. doi:10.1212/WNL.0000000000002790. PMC 4977114. PMID 27358333.
- ↑ Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR (August 2016). "Randomized Trial of Thymectomy in Myasthenia Gravis". N. Engl. J. Med. 375 (6): 511–22. doi:10.1056/NEJMoa1602489. PMC 5189669. PMID 27509100.
- ↑ Sonett JR, Jaretzki A (2008). "Thymectomy for nonthymomatous myasthenia gravis: a critical analysis". Ann. N. Y. Acad. Sci. 1132: 315–28. doi:10.1196/annals.1405.004. PMID 18567883.